SCHEMBL8646113

SCHEMBL8646113

CCCCC(=O)ONC(=O)c1cc(OCCCN)no1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 4/20 0.58
POLB P06746 1/20 0.36
ALDH1A1 P00352 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
ITGB3 P05106 2/20 0.33
ITGA2B P08514 2/20 0.33
KDM4E B2RXH2 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CSF1R P07333 1/20 0.32
PRSS1 P07477 1/20 0.31
PRSS2 P07478 1/20 0.31
PRSS3 P35030 1/20 0.31
TPSAB1 Q15661 1/20 0.31
PPARG P37231 2/20 0.31
PTGES O14684 1/20 0.31
ALOX5 P09917 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7401084 0.77 SMPD1 (0.50) SMPD1POLBALDH1A1KMT2AKDM4E
SCHEMBL12334447 0.72 SMPD1 (0.64) SMPD1POLBALDH1A1NPC1RAB9A
SCHEMBL1527370 0.69 SMPD1 (0.72) SMPD1ALDH1A1KMT2ATP53TSHR
SCHEMBL10194130 0.69 SMPD1 (0.60) SMPD1POLBALDH1A1TP53TSHR
SCHEMBL5888236 0.67 SMPD1 (0.58) SMPD1POLBALDH1A1NPC1RAB9A
SCHEMBL12621075 0.67 SMPD1 (0.58) SMPD1ALDH1A1KMT2ATP53TSHR
SCHEMBL2182229 0.65 SMPD1 (0.52) SMPD1ALDH1A1TP53KDM4E
SCHEMBL31286707 0.64 SMPD1 (0.50) SMPD1KMT2ATSHR
SCHEMBL27367994 0.63 ALDH1A1 (0.54) POLBALDH1A1NPC1RAB9AKMT2A
SCHEMBL31286775 0.63 SMPD1 (0.55) SMPD1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5710159-A IMIDAZOLIN-2-YLAMINOPROPOXY)ISOXAZOL-5-CARBONYLAMINO-2 -BENZYLOXYCARBONYLAMINOPROPIONIC ACID AS ANTIINFLAMMATORY AGENTS, BONE DEGRADATION, TUMORS, METASTASES AND THROMBOSIS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-01-20 US disclosed